Indian Government Tightens Oversight on GLP-1 Drugs Amid Rising Demand

The Indian government has issued a detailed advisory and increased regulatory surveillance on GLP-1 receptor agonist drugs, emphasizing their use for type 2 diabetes and obesity must be strictly under medical supervision due to rising demand and flagged risks.

1 Apr, 09:16 — 1 Apr, 09:16

Post Share

Sources

Showing 1 of 1 sources

Times of IndiaMostly Factual154d ago

Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details

The Centre has issued a detailed advisory on GLP-1 receptor agonist drugs, emphasizing their use for type 2 diabetes and obesity must be strictly under medical supervision. Authorities are increasing regulatory surveillance and warning of strict action against violations in their sale or prescription.

By TOI NEWS DESK

Read full article →

Indian Government Tightens Oversight on GLP-1 Drugs Amid Rising Demand

Sources

Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details

Related Stories

Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites

New Urine Test Detects Over 90 Percent of Bladder Cancer Cases

Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts

Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe